Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Drops By 56.3%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 3,452 shares, a decline of 56.3% from the July 30th total of 7,895 shares. Currently, 2.3% of the shares of the company are short sold. Based on an average daily volume of 4,508 shares, the short-interest ratio is presently 0.8 days.

iShares Neuroscience and Healthcare ETF Trading Down 2.7%

Shares of NYSEARCA:IBRN traded down $1.07 on Friday, reaching $39.23. 4,007 shares of the company’s stock were exchanged, compared to its average volume of 2,328. iShares Neuroscience and Healthcare ETF has a twelve month low of $25.00 and a twelve month high of $43.01. The company has a fifty day moving average of $38.54 and a 200-day moving average of $35.29. The company has a market capitalization of $5.88 million, a price-to-earnings ratio of 15.61 and a beta of 0.75.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.